Your browser doesn't support javascript.
loading
Diagnosis of 'possible' mitochondrial disease: an existential crisis.
Parikh, Sumit; Karaa, Amel; Goldstein, Amy; Bertini, Enrico Silvio; Chinnery, Patrick F; Christodoulou, John; Cohen, Bruce H; Davis, Ryan L; Falk, Marni J; Fratter, Carl; Horvath, Rita; Koenig, Mary Kay; Mancuso, Michaelangelo; McCormack, Shana; McCormick, Elizabeth M; McFarland, Robert; Nesbitt, Victoria; Schiff, Manuel; Steele, Hannah; Stockler, Silvia; Sue, Carolyn; Tarnopolsky, Mark; Thorburn, David R; Vockley, Jerry; Rahman, Shamima.
Affiliation
  • Parikh S; Mitochondrial Medicine Center, Neurologic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Karaa A; Genetics Unit, Mitochondrial Disease Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Goldstein A; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Bertini ES; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Chinnery PF; Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Christodoulou J; MRC Mitochondrial Biology Unit and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Cohen BH; Neurodevelopmental Genomics Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Davis RL; Department of Paediatrics, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
  • Falk MJ; Department of Pediatrics and Rebecca D. Considine Research Institute, Akron Children's Hospital, Akron, Ohio, USA.
  • Fratter C; Northeast Ohio Medical University, Rootstown, Ohio, USA.
  • Horvath R; Northern Clinical School, University of Sydney, Sydney, New South Wales, Australia.
  • Koenig MK; Department of Neurogenetics, Koling Institute, University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Mancuso M; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • McCormack S; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • McCormick EM; NHS Specialized Services for Rare Mitochondrial Disorders of Adults and Children UK, Oxford, UK.
  • McFarland R; Oxford Medical Genetics Laboratories, Oxford University, Oxford, UK.
  • Nesbitt V; Wellcome Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Schiff M; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Steele H; Department of Pediatrics, Mitochondrial Center, University of Texas McGovern Medical School, Houston, Texas, USA.
  • Stockler S; Department of Experimental and Clinical Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
  • Sue C; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Tarnopolsky M; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Thorburn DR; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Vockley J; Institute of Neurosciences, Wellcome Trust Centre for Mitochondrial Research, Newcastle University, Newcastle, UK.
  • Rahman S; Institute of Neurosciences, Wellcome Trust Centre for Mitochondrial Research, Newcastle University, Newcastle, UK.
J Med Genet ; 56(3): 123-130, 2019 03.
Article in En | MEDLINE | ID: mdl-30683676
ABSTRACT
Primary genetic mitochondrial diseases are often difficult to diagnose, and the term 'possible' mitochondrial disease is used frequently by clinicians when such a diagnosis is suspected. There are now many known phenocopies of mitochondrial disease. Advances in genomic testing have shown that some patients with a clinical phenotype and biochemical abnormalities suggesting mitochondrial disease may have other genetic disorders. In instances when a genetic diagnosis cannot be confirmed, a diagnosis of 'possible' mitochondrial disease may result in harm to patients and their families, creating anxiety, delaying appropriate diagnosis and leading to inappropriate management or care. A categorisation of 'diagnosis uncertain', together with a specific description of the metabolic or genetic abnormalities identified, is preferred when a mitochondrial disease cannot be genetically confirmed.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Predisposition to Disease / Mitochondrial Diseases / Genetic Association Studies Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Med Genet Year: 2019 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Predisposition to Disease / Mitochondrial Diseases / Genetic Association Studies Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Med Genet Year: 2019 Document type: Article Affiliation country: United States